350 related articles for article (PubMed ID: 27072054)
1. Social/economic costs and health-related quality of life in patients with fragile X syndrome in Europe.
Chevreul K; Gandré C; Brigham KB; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Gulácsi L; von der Schulenburg JM; Kanavos P; Persson U; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1():43-52. PubMed ID: 27072054
[TBL] [Abstract][Full Text] [Related]
2. Social/economic costs and health-related quality of life in patients with Duchenne muscular dystrophy in Europe.
Cavazza M; Kodra Y; Armeni P; De Santis M; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Péntek M; von der Schulenburg JM; Kanavos P; Chevreul K; Persson U; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1():19-29. PubMed ID: 27038625
[TBL] [Abstract][Full Text] [Related]
3. Social/economic costs and health-related quality of life in patients with epidermolysis bullosa in Europe.
Angelis A; Kanavos P; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Brodszky V; von der Schulenburg JM; Chevreul K; Persson U; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1(Suppl 1):31-42. PubMed ID: 27107597
[TBL] [Abstract][Full Text] [Related]
4. Social/economic costs and health-related quality of life in patients with Prader-Willi syndrome in Europe.
López-Bastida J; Linertová R; Oliva-Moreno J; Posada-de-la-Paz M; Serrano-Aguilar P; Kanavos P; Taruscio D; Schieppati A; Iskrov G; Baji P; Delgado C; von der Schulenburg JM; Persson U; Chevreul K; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1():99-108. PubMed ID: 27038627
[TBL] [Abstract][Full Text] [Related]
5. Social/economic costs and quality of life in patients with haemophilia in Europe.
Cavazza M; Kodra Y; Armeni P; De Santis M; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Gulácsi L; von der Schulenburg JM; Kanavos P; Chevreul K; Persson U; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1():53-65. PubMed ID: 27048374
[TBL] [Abstract][Full Text] [Related]
6. Social/economic costs and health-related quality of life of mucopolysaccharidosis patients and their caregivers in Europe.
Péntek M; Gulácsi L; Brodszky V; Baji P; Boncz I; Pogány G; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Iskrov G; Schieppati A; von der Schulenburg JM; Kanavos P; Chevreul K; Persson U; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1():89-98. PubMed ID: 27062257
[TBL] [Abstract][Full Text] [Related]
7. Fragile X syndrome: economic burden and health-related quality of life of patients and caregivers in France.
Chevreul K; Berg Brigham K; Brunn M; des Portes V;
J Intellect Disabil Res; 2015 Dec; 59(12):1108-20. PubMed ID: 26369667
[TBL] [Abstract][Full Text] [Related]
8. Social/economic costs and health-related quality of life in patients with juvenile idiopathic arthritis in Europe.
Kuhlmann A; Schmidt T; Treskova M; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Kanavos P; Taruscio D; Schieppati A; Iskrov G; Péntek M; Delgado C; von der Schulenburg JM; Persson U; Chevreul K; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1():79-87. PubMed ID: 27086322
[TBL] [Abstract][Full Text] [Related]
9. Social/economic costs and health-related quality of life in patients with scleroderma in Europe.
López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Kanavos P; Taruscio D; Schieppati A; Iskrov G; Péntek M; Delgado C; von der Schulenburg JM; Persson U; Chevreul K; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1():109-17. PubMed ID: 27038626
[TBL] [Abstract][Full Text] [Related]
10. Social/economic costs and health-related quality of life in patients with histiocytosis in Europe.
Iskrov G; Astigarraga I; Stefanov R; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Schieppati A; Taruscio D; Péntek M; von der Schulenburg JM; Kanavos P; Chevreul K; Persson U; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1():67-78. PubMed ID: 27042831
[TBL] [Abstract][Full Text] [Related]
11. Social/economic costs and health-related quality of life in patients with cystic fibrosis in Europe.
Chevreul K; Michel M; Brigham KB; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Péntek M; von der Schulenburg JM; Kanavos P; Persson U; Fattore G;
Eur J Health Econ; 2016 Apr; 17 Suppl 1():7-18. PubMed ID: 27059622
[TBL] [Abstract][Full Text] [Related]
12. Social and economic costs and health-related quality of life in non-institutionalised patients with cystic fibrosis in the United Kingdom.
Angelis A; Kanavos P; López-Bastida J; Linertová R; Nicod E; Serrano-Aguilar P;
BMC Health Serv Res; 2015 Sep; 15():428. PubMed ID: 26416027
[TBL] [Abstract][Full Text] [Related]
13. Economic burden and health-related quality of life associated with Prader-Willi syndrome in France.
Chevreul K; Berg Brigham K; Clément MC; Poitou C; Tauber M;
J Intellect Disabil Res; 2016 Sep; 60(9):879-90. PubMed ID: 27174598
[TBL] [Abstract][Full Text] [Related]
14. Understanding the socioeconomic costs of dystrophic epidermolysis bullosa in Europe: a costing and health-related quality of life study.
Angelis A; Mellerio JE; Kanavos P
Orphanet J Rare Dis; 2022 Sep; 17(1):346. PubMed ID: 36068590
[TBL] [Abstract][Full Text] [Related]
15. The economic burden and health-related quality of life associated with systemic sclerosis in France.
Chevreul K; Brigham KB; Gandré C; Mouthon L;
Scand J Rheumatol; 2015 May; 44(3):238-46. PubMed ID: 25521915
[TBL] [Abstract][Full Text] [Related]
16. Socioeconomic costs and health-related quality of life in juvenile idiopathic arthritis: a cost-of-illness study in the United Kingdom.
Angelis A; Kanavos P; López-Bastida J; Linertová R; Serrano-Aguilar P;
BMC Musculoskelet Disord; 2016 Aug; 17():321. PubMed ID: 27484740
[TBL] [Abstract][Full Text] [Related]
17. The Economic Impact and Health-Related Quality of Life of Spinal Muscular Atrophy. An Analysis across Europe.
Peña-Longobardo LM; Aranda-Reneo I; Oliva-Moreno J; Litzkendorf S; Durand-Zaleski I; Tizzano E; López-Bastida J
Int J Environ Res Public Health; 2020 Aug; 17(16):. PubMed ID: 32764338
[No Abstract] [Full Text] [Related]
18. Patient and Caregiver Burden Associated With Fragile X Syndrome in the United States.
Vekeman F; Gauthier-Loiselle M; Faust E; Lefebvre P; Lahoz R; Duh MS; Sacco P
Am J Intellect Dev Disabil; 2015 Sep; 120(5):444-59. PubMed ID: 26322391
[TBL] [Abstract][Full Text] [Related]
19. Economic burden and health-related quality of life in tenosynovial giant-cell tumour patients in Europe: an observational disease registry.
Lopez-Bastida J; Aranda-Reneo I; Rodríguez-Sánchez B; Peña-Longobardo LM; Ye X; Laeis P; Fronk EM; Palmerini E; Leithner A; Van de Sande MAJ
Orphanet J Rare Dis; 2021 Jul; 16(1):294. PubMed ID: 34215312
[TBL] [Abstract][Full Text] [Related]
20. Burden of illness among patients with fragile X syndrome (FXS): a Medicaid perspective.
Nazareth T; Li N; Marynchenko M; Zhou Z; Chopra P; Signorovitch J; Wu E; Ahmed S; Marvel J; Sasane R
Curr Med Res Opin; 2016; 32(3):405-16. PubMed ID: 26565934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]